160 related articles for article (PubMed ID: 27862025)
1. A review of muscle- and performance-based assessment instruments in DM1.
Symonds T; Campbell P; Randall JA
Muscle Nerve; 2017 Jul; 56(1):78-85. PubMed ID: 27862025
[TBL] [Abstract][Full Text] [Related]
2. Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.
Symonds T; Randall JA; Campbell P
Muscle Nerve; 2017 Jul; 56(1):86-92. PubMed ID: 27862031
[TBL] [Abstract][Full Text] [Related]
3. Lower limb muscle impairment in myotonic dystrophy type 1: the need for better guidelines.
Petitclerc É; Hébert LJ; Desrosiers J; Gagnon C
Muscle Nerve; 2015 Apr; 51(4):473-8. PubMed ID: 25399769
[TBL] [Abstract][Full Text] [Related]
4. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1).
Moxley RT; Logigian EL; Martens WB; Annis CL; Pandya S; Moxley RT; Barbieri CA; Dilek N; Wiegner AW; Thornton CA
Muscle Nerve; 2007 Sep; 36(3):320-8. PubMed ID: 17587223
[TBL] [Abstract][Full Text] [Related]
5. Functional impairment in patients with myotonic dystrophy type 1 can be assessed by an ataxia rating scale (SARA).
DiPaolo G; Jimenez-Moreno C; Nikolenko N; Atalaia A; Monckton DG; Guglieri M; Lochmüller H
J Neurol; 2017 Apr; 264(4):701-708. PubMed ID: 28168524
[TBL] [Abstract][Full Text] [Related]
6. Lower limb muscle strength impairment in late-onset and adult myotonic dystrophy type 1 phenotypes.
Petitclerc É; Hébert LJ; Mathieu J; Desrosiers J; Gagnon C
Muscle Nerve; 2017 Jul; 56(1):57-63. PubMed ID: 27784130
[TBL] [Abstract][Full Text] [Related]
7. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy.
Logigian EL; Ciafaloni E; Quinn LC; Dilek N; Pandya S; Moxley RT; Thornton CA
Muscle Nerve; 2007 Apr; 35(4):479-85. PubMed ID: 17230537
[TBL] [Abstract][Full Text] [Related]
8. Quantitative myotonia assessment with a commercially available dynamometer in myotonic dystrophy types 1 and 2.
Horáková M; Horák T; Parmová O; Bednařík J; Voháňka S
Muscle Nerve; 2019 Apr; 59(4):431-435. PubMed ID: 30575988
[TBL] [Abstract][Full Text] [Related]
9. Intra-Rater Reliability and Concurrent Validity of Quantified Muscle Testing for Maximal Knee Extensors Strength in Men with Myotonic Dystrophy Type 1.
Roussel MP; Hébert LJ; Duchesne E
J Neuromuscul Dis; 2019; 6(2):233-240. PubMed ID: 31127731
[TBL] [Abstract][Full Text] [Related]
10. Quality of life in patients with myotonic dystrophy type 2.
Rakocevic Stojanovic V; Peric S; Paunic T; Pesovic J; Vujnic M; Peric M; Nikolic A; Lavrnic D; Savic Pavicevic D
J Neurol Sci; 2016 Jun; 365():158-61. PubMed ID: 27206898
[TBL] [Abstract][Full Text] [Related]
11. Validation of the Nine Hole Peg Test as a measure of dexterity in myotonic dystrophy type 1.
Cutellè C; Rastelli E; Gibellini M; Greco G; Frezza E; Botta A; Terracciano C; Massa R
Neuromuscul Disord; 2018 Nov; 28(11):947-951. PubMed ID: 30270126
[TBL] [Abstract][Full Text] [Related]
12. Is one trial enough for repeated testing? Same-day assessments of walking, mobility and fine hand use in people with myotonic dystrophy type 1.
Kierkegaard M; Petitclerc E; Hébert LJ; Gagnon C
Neuromuscul Disord; 2017 Feb; 27(2):153-158. PubMed ID: 28062219
[TBL] [Abstract][Full Text] [Related]
13. The use of muscle strength assessed with handheld dynamometers as a non-invasive biological marker in myotonic dystrophy type 1 patients: a multicenter study.
Hébert LJ; Remec JF; Saulnier J; Vial C; Puymirat J
BMC Musculoskelet Disord; 2010 Apr; 11():72. PubMed ID: 20398425
[TBL] [Abstract][Full Text] [Related]
14. Poor sleep quality and fatigue but no excessive daytime sleepiness in myotonic dystrophy type 2.
Tieleman AA; Knoop H; van de Logt AE; Bleijenberg G; van Engelen BG; Overeem S
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):963-7. PubMed ID: 20798200
[TBL] [Abstract][Full Text] [Related]
15. MRI of trunk muscles and motor and respiratory function in patients with myotonic dystrophy type 1.
Solbakken G; Bjørnarå B; Kirkhus E; Nguyen B; Hansen G; Frich JC; Ørstavik K
BMC Neurol; 2019 Jun; 19(1):135. PubMed ID: 31216995
[TBL] [Abstract][Full Text] [Related]
16. Responsiveness of outcome measures in myotonic dystrophy type 1.
Knak KL; Sheikh AM; Witting N; Vissing J
Ann Clin Transl Neurol; 2020 Aug; 7(8):1382-1391. PubMed ID: 32672404
[TBL] [Abstract][Full Text] [Related]
17. Assessment of muscular strength and functional capacity in the juvenile and adult myotonic dystrophy type 1 population: a 3-year follow-up study.
Roussel MP; Fiset MM; Gauthier L; Lavoie C; McNicoll É; Pouliot L; Gagnon C; Duchesne E
J Neurol; 2021 Nov; 268(11):4221-4237. PubMed ID: 33907889
[TBL] [Abstract][Full Text] [Related]
18. Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).
Heatwole C; Bode R; Johnson N; Quinn C; Martens W; McDermott MP; Rothrock N; Thornton C; Vickrey B; Victorson D; Moxley R
Neurology; 2012 Jul; 79(4):348-57. PubMed ID: 22786587
[TBL] [Abstract][Full Text] [Related]
19. Outcome measures frequently used to assess muscle strength in patients with myotonic dystrophy type 1: a systematic review.
Mateus T; Costa A; Viegas D; Marques A; Herdeiro MT; Rebelo S
Neuromuscul Disord; 2022 Feb; 32(2):99-115. PubMed ID: 35031191
[TBL] [Abstract][Full Text] [Related]
20. Major involvement of trunk muscles in myotonic dystrophy type 1.
Solbakken G; Ørstavik K; Hagen T; Dietrichs E; Naerland T
Acta Neurol Scand; 2016 Dec; 134(6):467-473. PubMed ID: 26984572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
